Harnessing the power of Imaging Phenomics

At Median, we’re transforming the science of medical imaging. By harnessing the power of Imaging Phenomics we can improve current treatment, enhance diagnosis and accelerate development of next generation therapies, helping make a healthier world for millions.

The fight against disease is a joint effort

While our expertise and resources are unique, we don’t work alone. The fight against disease is a joint effort and the spirit of cooperation is found in everything we do. Whether working in clinical trials or patient care and treatment, we share the same single-minded goal. To defeat the diseases that still touch so many lives.

Pushing the boundaries of imaging technology

At Median we’re determined to push the boundaries of what imaging technology can achieve, to help develop next generation treatments with the potential to save or improve the lives of millions.

CEO’s message


Fredrik Brag talks about how we’re looking to change the game. To transform the landscape in which we work and create a new world of possibilities for biopharma companies and healthcare professionals alike.

Read more

The Imaging Phenomics Company™

Median Technologies is the Imaging Phenomics Company™. Learn about our Lesion Management Solution (LMS) technology and iBiopsy®, our Imaging Biomarker Phenotyping System.

Watch

News

19 October 2017

Median Technologies appoints Vivian Wang as General Manager, China and Takashi Hayashi as Managing Director, Japan

Vivian Wang and Takashi Hayashi will strengthen Median’s growth in Asia. With these appointments, and the recently announced opening of its subsidiary in Hong Kong, Median intends to significantly invest in and grow its business in the Asian market.

17 October 2017

Median Technologies to attend The Liver Meeting® of The American Association for the Study of Liver Diseases to be held October 20-24, 2017 in Washington, DC, USA

Press release – For immediate release – 5:45pm CEST Median Technologies will showcase its iBiopsy® platform for liver diseases at booth #241. The Imaging…

10 October 2017

H1 2017 results: half-year marked by major investments to structure the company and prepare for the future

Median Technologies (ALMDT:PA) The Imaging Phenomics Company®, has published its H1 2017 results.

6 September 2017

Median Technologies to attend the ESMO 2017 Congress, September 8-12, 2017, Madrid, Spain

Median Technologies, the Imaging Phenomics Company®, announced today that it will be exhibiting at the ESMO 2017 Congress, September 8-12 at IFEMA, Feria de Madrid, Spain (exhibition dates: Sept. 8-11). Median Technologies will share and showcase its imaging solutions and services at booth #233

5 September 2017

Median Technologies to lead a scientific and medical round table to discuss the application of its groundbreaking imaging phenomics platform iBiopsy® for Nonalcoholic Steatohepatitis (NASH)

Panelists will include four world-renowned key opinion leaders in the fields of hepatology, liver imaging, biomarker and non-invasive test development and clinical trial design. The round table will be held on September 7th, 2017 in Sophia Antipolis, France.

1/5

Opinion

12 October 2017
Different Types of Imaging Criteria: Morphological Measures

Different Types of Imaging Criteria: Morphological Measures

Different Types of Imaging Criteria: Morphological Measures In oncology clinical trials, therapy is generally assessed using imaging response criteria involving imaging biomarkers. Imaging…

11 July 2017
Super Resolution Imaging – For Better Medical Image Analysis

Super Resolution Imaging – For Better Medical Image Analysis

Super Resolution Imaging – For Better Medical Image Analysis If you are fan of science fiction films and you are 40+ like me,…

30 May 2017
Why Cultural Fit Matters when Selecting an Imaging CRO

Why Cultural Fit Matters when Selecting an Imaging CRO

Why Cultural Fit Matters when Selecting an Imaging CRO In the clinical trials process, high quality imaging used as surrogate endpoints significantly improves…

16 May 2017
Minimizing Variability in Imaging Reads for Clinical trials

Minimizing Variability in Imaging Reads for Clinical trials

Minimizing Variability in Imaging Reads for Clinical trials In oncology, response to treatment is typically assessed by measuring tumor size and growth over…

2 May 2017
Putting patient needs first improves engagement – from recruitment to their last medical image.

Putting patient needs first improves engagement – from recruitment to their last medical image.

Putting patient needs first improves patient engagement in a clinical trial, and delivers a better experience for everyone involved – from recruitment to…

1/5
Imaging for patient care

Identifying treatments that work

Imaging biomarkers provide a unique insight into treatment progress at every stage of a disease. In cancer for instance, comprehensive quantitative information plays an invaluable role in defining, tracking and measuring treatment outcomes. Providing clear evidence of what works and what doesn’t.

Read more

Imaging for clinical trials

Advancing treatments of the future

Working with biopharmaceutical companies, and leading medical centers around the world, the team at Median enable researchers to identify disease fingerprints from medical images. We’re helping paving the way for new personalized and innovative medicines, more accurate and predictable diagnoses and better treatments

Read more

Ibiopsy®

Powering the phenomics revolution

We’re changing the game; transforming the landscape. We’re capturing the power of big data and unique biomarker imaging technology to create a new world of possibilities for biopharma and healthcare professionals alike. Our iBiopsy® platform opens up the field of phenomics, driving the science of precision medicine.

Read more

Investors

Delivering value

Our technology and expertise is creating a new world of possibilities for biopharmaceutical and healthcare professionals around the world. By successfully helping improve the lives of millions, we are also delivering value for our investors and partners.

Read more

Stock Market Data

TICKER: ALMDT ISIN: FR0011049824
Get in touch

europe

Median Technologies
Les Deux Arcs, Bât B
1800, route des Crêtes
06560 Valbonne
France

Get in touch

Get in touch





Jobs at Median

United States

Legal address
Median Technologies Inc
C/O Pramex International
1251 Avenue of the Americas
3rd Floor
New York NY 10020

US offices

Median Technologies Inc
300 TradeCenter
Suite 5610
Woburn MA 01801

Cookies help us deliver our services. By using our services, you agree to our use of cookies.